Search global stocks & ETFs...Ctrl K
Learn Mode
BAX logo
Baxter International IncBAX
$19.39
-$1.07 (-5.230%)
at close
$19.59
$0.20 (1.008%)
pre market · 8:05 AM
General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Updates
BAX
Stock Profile
Market Cap
$10.01B
Industry
Health Care
EPS (TTM)
-$2.13
P/E (TTM)
0.00
Div & Yield
$0.04 (0.21%)
FCF Payout Ratio
2.86%
P/S (TTM)
0.88
P/B
1.66
Revenue Growth (TTM)
-4.79%
EPS CAGR (3Y)
0.00%
Diluted Shares
515.00M
Ex-Dividend
2026-05-29
Next Earnings
07-29
Forward P/E
9.81
Payout Ratio
0.00%
P/FCF (TTM)
13.85
FCF Yield
7.22%
Earnings Yield
-10.96%
Revenue CAGR (3Y)
-7.84%
Recommended Metric
2.42
Bad
Baxter International Inc has seen its revenue decline by -4.79% over the past year, which means the company is losing sales/customers. Also, it has an operating margin of 4.07%, which suggests the operations are not very profitable.
Valuation Score
Key Score
2.00
Bad
Management
3.00
Average

Growth
2.00
Bad

Profitability
4.00
Good
Fin. Health
2.00
Bad

Dividends
2.00
Bad

Analyst
1.00
Very Bad
Revenue
Earnings
Free Cash Flow
Insider Transactions
Explore Insider Tab ›
Buy Transactions
Sell Transactions
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$19.39
Baseline
High
$42.35
118.39%
Avg
$21.88
12.86%
Low
$15.15
-21.87%
Analyst Ratings based on 24 Analysts
Strong Buy
0
00%
Buy
1
04%
Hold
16
67%
Sell
5
21%
Strong Sell
2
08%
Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company is headquartered in Deerfield, Illinois and currently employs 37,500 full-time employees. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. Its products are used in hospitals, rehabilitation centers, ambulatory surgery centers, and others.Read More

IPO Date
1961-05-15

Industry
Health Care

Total Employees
37,500

Exchange
New York Stock Exchange, Inc.

Reporting Currency
USD

GICS
Health Care Equipment & Supplies

GICS Sub
Health Care Equipment

GICS Sector
Health Care

GICS Group
Health Care Equipment & Services